Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Transpire Bio
Transpire Bio

Transpire Bio

Angel

Transire Bio: Innovating painless delivery of injectable drugs through inhaled medicine development.

HQ
Weston, FL, US
Founded
2022
Overview
Compare
Fundraising
Employees

Transpire Bio, founded with a mission to revolutionize drug delivery, focuses on developing inhaled medicines that provide painless alternatives to traditional injectable drugs. The company aims to enhance patient access to essential therapies and create innovative treatment options for serious diseases. Transpire Bio's core offerings include inhalation therapies for both lung and systemic diseases, positioning itself as a leader in the biotechnology sector with a strong emphasis on patient-centric solutions.

Notable figures associated with Transpire Bio include a leadership team of experienced professionals and subject matter technical experts dedicated to advancing inhalation therapy. The company has achieved significant milestones in its drug development pipeline, reflecting its commitment to cutting-edge science and patient care. Through strategic partnerships and a robust research agenda, Transpire Bio is making a substantial impact on the healthcare industry, offering promising alternatives to conventional drug delivery methods.

Transpire Bio - Similar Companies

Respira Therapeutics logo

Respira Therapeutics

Qnovia logo

Qnovia

qnovia.com

Kinaset Therapeutics logo

Kinaset Therapeutics

kinasettx.com

Inhalon Biopharma logo

Inhalon Biopharma

inhalon.com

Syntis Bio logo

Syntis Bio

syntis.bio

Portal Instruments logo

Portal Instruments

Surf Bio logo

Surf Bio

surf.bio

Vitranu logo

Vitranu

vitranu.com

Spyryx Biosciences logo

Spyryx Biosciences

i2o Therapeutics logo

i2o Therapeutics

i2obio.com

Pulmatrix logo

Pulmatrix

pulmatrix.com

BioQ Pharma logo

BioQ Pharma

bioqpharma.com

Synspira logo

Synspira

Aer Therapeutics logo

Aer Therapeutics

BioSuperior logo

BioSuperior

bio-superior.com

Transpire Bio - Quick Facts

Who are Transpire Bio's competitors?

Companies similar to Transpire Bio include Respira Therapeutics, Qnovia, Kinaset Therapeutics and Inhalon Biopharma.

When was Transpire Bio founded?

Transpire Bio was founded in 2022.

Where is Transpire Bio's headquarters located?

Transpire Bio's headquarters is located in Weston, FL, US.

When was Transpire Bio's last funding round?

Transpire Bio's most recent funding round was for $10k (USD) in July 2023.

How much has Transpire Bio raised to-date?

As of Jul 27, 2023, Transpire Bio has raised a total of $10k (USD).

How many employees does Transpire Bio have?

Transpire Bio has 30 employees as of Feb 4, 2024.

Transpire Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Inhaled Medicines
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified